Related references
Note: Only part of the references are listed.Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin 1 efficacy trials in the light of a combination therapy approach
P. H. Naylor et al.
JOURNAL OF VIRAL HEPATITIS (2018)
New Classification of Liver Biopsy Assessment for Fibrosis in Chronic Hepatitis B Patients Before and After Treatment
Yameng Sun et al.
HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Liver Fibrosis Reversion After Suppression of Hepatitis B Virus
Don C. Rockey
CLINICS IN LIVER DISEASE (2016)
Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity
Melisa Dirchwolf et al.
CYTOKINE (2016)
A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol
Shuang-Jian Qiu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Dual effect of Thymosin α 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonists
Elena Giacomini et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Reversibility of hepatitis B virus cirrhosis after therapy: who and why?
Pierre Bedossa
LIVER INTERNATIONAL (2015)
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2014)
Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B
Grace Lai-Hung Wong et al.
JOURNAL OF HEPATOLOGY (2014)
Thymosin α1 and cancer: action on immune effector and tumor target cells
Enrico Garaci et al.
THYMOSINS IN HEALTH AND DISEASE I (2012)
Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study
Bo Hyun Kim et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Thymosin alpha 1: past clinical experience and future promise
Cynthia Tuthill et al.
THYMOSINS IN HEALTH AND DISEASE (2010)
Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis
M. Marquez et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
From lab to bedside: emerging clinical applications of thymosin alpha(1)
Allan L. Goldstein et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Treatment with lamivudine versus lamivudine and thymosin alpha-I for e antigen-positive chronic hepatitis B patients: a meta-analysis
Yuan-Yuan Zhang et al.
VIROLOGY JOURNAL (2009)
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
Yuan-Yuan Zhang et al.
VIROLOGY JOURNAL (2009)
Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis
Yong-Feng Yang et al.
ANTIVIRAL RESEARCH (2008)
Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study
Hyun Woong Lee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Thymosin-α1 increases intrahepatic NKT cells and CTLs in patients with chronic hepatitis B
S Sugahara et al.
HEPATOLOGY RESEARCH (2002)
The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis
HLY Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application
E Garaci et al.
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY (2000)
Share Paper
